HealthQuill Boston Scientific Corporation
ohnson & Johnson paused its rollout of a heart device to treat atrial fibrillationĀ ā€œout of an abundance of caution,ā€ as it probes four cases of neurovascular events related to the device.
Health Medical Pharma

J&J pauses rollout of heart device in US after ischemic, stroke incidents

ohnson & Johnson paused its rollout of a heart device to treat atrial fibrillationĀ ā€œout of an abundance of caution,ā€ as it probes four.

Read More
Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low back pain segment.
Health Medical Pharma

Boston Scientific acquires Relevant Medsystems for $850m

HQ Team September 20, 2023: Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low.

Read More